ArticleMolecular genetics and metabolism reports2016

Stability is maintained in adults with Gaucher disease type 1 switched from velaglucerase alfa to eliglustat or imiglucerase: A sub-analysis of the eliglustat ENCORE trial.

Rebecca Pleat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.